Society guideline links: Bronchopulmonary dysplasia

Introduction —

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Pulmonary hypertension in children".)

Canada

●Canadian Paediatric Society (CPS): Guidelines for surfactant replacement therapy in neonates (2021)

●CPS: Position statement on postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia in preterm infants (2020)

United States

●American Thoracic Society (ATS): Clinical practice guideline on outpatient respiratory management of infants, children, and adolescents with post-prematurity respiratory disease (2021)

●American Academy of Pediatrics (AAP): Policy statement on postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia (2010, reaffirmed 2020)

●AAP: Clinical report on noninvasive respiratory support (2016)

●ATS: Clinical practice guideline on home oxygen therapy for children (2018)

●AAP: Clinical report on the use of inhaled nitric oxide in preterm infants (2014)

●AAP: Policy statement on respiratory support in preterm infants at birth (2014)

●ATS: Workshop report – Optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing in children less than 6 years of age (2013)